Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Northwest Biotherapeutics (NWBO) Shares Issued (2016 - 2025)

Historic Shares Issued for Northwest Biotherapeutics (NWBO) over the last 17 years, with Q3 2025 value amounting to $4.9 million.

  • Northwest Biotherapeutics' Shares Issued fell 3165.59% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.5 million, marking a year-over-year increase of 11233.96%. This contributed to the annual value of $14.2 million for FY2024, which is 72801.4% up from last year.
  • Per Northwest Biotherapeutics' latest filing, its Shares Issued stood at $4.9 million for Q3 2025, which was down 3165.59% from $7.3 million recorded in Q2 2025.
  • In the past 5 years, Northwest Biotherapeutics' Shares Issued registered a high of $8.0 million during Q3 2021, and its lowest value of $32000.0 during Q3 2023.
  • In the last 5 years, Northwest Biotherapeutics' Shares Issued had a median value of $3.3 million in 2021 and averaged $3.4 million.
  • As far as peak fluctuations go, Northwest Biotherapeutics' Shares Issued crashed by 9464.84% in 2022, and later soared by 2213125.0% in 2024.
  • Over the past 5 years, Northwest Biotherapeutics' Shares Issued (Quarter) stood at $7.9 million in 2021, then crashed by 85.82% to $1.1 million in 2022, then crashed by 89.37% to $119000.0 in 2023, then skyrocketed by 3434.45% to $4.2 million in 2024, then grew by 15.6% to $4.9 million in 2025.
  • Its Shares Issued stands at $4.9 million for Q3 2025, versus $7.3 million for Q2 2025 and $5.1 million for Q1 2025.